The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NUC-1031 in combination with cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Mairead Geraldine McNamara
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Speakers' Bureau - Nucana; Nucana; Nucana; Nucana
Research Funding - Ipsen; Ipsen; Ipsen; Ipsen; Nucana; Nucana; Nucana; Nucana; SERVIER; SERVIER; SERVIER; SERVIER
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Lipika Goyal
Consulting or Advisory Role - Agios; Agios; Agios; Agios; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals
 
Mark Doherty
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Eisai; Eisai; Eisai; Eisai; Merck; Merck; Merck; Merck; Roche Canada; Roche Canada; Roche Canada; Roche Canada
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Christoph Springfeld
No Relationships to Disclose
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene
Research Funding - Celgene; Celgene; Celgene; Celgene
 
Aimery De Gramont
Honoraria - Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical; Yakult Pharmaceutical
 
Helena Verdaguer
No Relationships to Disclose
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Aimmune; Aimmune; Aimmune; Aimmune; Alnylam; Alnylam; Alnylam; Alnylam; Biomarin; Biomarin; Biomarin; Biomarin; Bluebird Bio; Bluebird Bio; Bluebird Bio; Bluebird Bio; Cochlear; Cochlear; Cochlear; Cochlear; CSL Limited; CSL Limited; CSL Limited; CSL Limited; Dova Pharmaceuticals; Dova Pharmaceuticals; Dova Pharmaceuticals; Dova Pharmaceuticals; GW Pharmaceuticals; GW Pharmaceuticals; GW Pharmaceuticals; GW Pharmaceuticals; Juno Therapeutics; Juno Therapeutics; Juno Therapeutics; Juno Therapeutics; Kiadis Pharma; Kiadis Pharma; Kiadis Pharma; Kiadis Pharma; Kite, a Gilead company; Kite, a Gilead company; Kite, a Gilead company; Kite, a Gilead company; Sage Therapeutics; Sage Therapeutics; Sage Therapeutics; Sage Therapeutics; TherapeuticsMD; TherapeuticsMD; TherapeuticsMD; TherapeuticsMD; Vertex; Vertex; Vertex; Vertex
Honoraria - Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Halozyme; Halozyme; Halozyme; Halozyme; Merck Serono; Merck Serono; Merck Serono; Merck Serono; pfizer; pfizer; pfizer; pfizer; Specialised Therapeutics; Specialised Therapeutics; Specialised Therapeutics; Specialised Therapeutics; Targovax; Targovax; Targovax; Targovax
Consulting or Advisory Role - Halozyme; Halozyme; Halozyme; Halozyme; Lipotek; Lipotek; Lipotek; Lipotek; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer; Pfizer; Pfizer; Pfizer; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; Targovax; Targovax; Targovax; Targovax
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Baxalta/Shire (Inst); Baxalta/Shire (Inst); Baxalta/Shire (Inst); Baxalta/Shire (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Specialised Therapeutics (Inst); Specialised Therapeutics (Inst); Specialised Therapeutics (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Deciphera; Deciphera; Deciphera; Deciphera; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Daniel H. Palmer
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Nucana; Nucana; Nucana; Nucana; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Nucana; Nucana; Nucana; Nucana; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Consulting or Advisory Role - Karus Therapeutics (Inst); Karus Therapeutics (Inst); Karus Therapeutics (Inst); Karus Therapeutics (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Basilea (Inst); Basilea (Inst); Basilea (Inst); Basilea (Inst); Beigene (Inst); Beigene (Inst); Beigene (Inst); Beigene (Inst); Bicycle Therapeutics (Inst); Bicycle Therapeutics (Inst); Bicycle Therapeutics (Inst); Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Medivir (Inst); Medivir (Inst); Medivir (Inst); Medivir (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); MiNA Therapeutics (Inst); MiNA Therapeutics (Inst); MiNA Therapeutics (Inst); MiNA Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Sanofi/Aventis (Inst); Sanofi/Aventis (Inst); Sanofi/Aventis (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre
Other Relationship - Genmab; Genmab; Genmab; Genmab
 
Paul J. Ross
Honoraria - Eisai; Eisai; Eisai; Eisai; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Speakers' Bureau - Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; SERVIER; Shire; Shire; Shire; Shire; Shire; Shire; Shire; Shire
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER
 
Juan W. Valle
Honoraria - Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Agios; Agios; Agios; Agios; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Genoscience Pharma; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Keocyt; Keocyt; Keocyt; Keocyt; Merck; Merck; Merck; Merck; Mundipharma; Mundipharma; Mundipharma; Mundipharma; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana; PCI Biotech; PCI Biotech; PCI Biotech; PCI Biotech; Pfizer; Pfizer; Pfizer; Pfizer; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics; SERVIER; SERVIER; SERVIER; SERVIER; Wren Laboratories; Wren Laboratories; Wren Laboratories; Wren Laboratories
Speakers' Bureau - Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Imaging Equipment Limited; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Nucana; Nucana; Nucana; Nucana
Research Funding - Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene; Nucana; Nucana; Nucana; Nucana; Pfizer; Pfizer; Pfizer; Pfizer